Motohiko Sano

The Japanese version of the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE): psychometric validation and discordance between clinician and patient assessments of adverse events

Takashi Kawaguchi, Kanako Azuma, Motohiko Sano et al. · Journal of Patient-Reported Outcomes · 2018 · 250 citations · Full text

Health Professions, Oncology, Cancer Control +8

Effect of calcium and magnesium on neurotoxicity and blood platinum concentrations in patients receiving mFOLFOX6 therapy: a prospective randomized study

Keiichiro Ishibashi, Norimichi Okada, Tatsuya Miyazaki et al. · International Journal of Clinical Oncology · 2010 · 65 citations

Pharmacy, Pharmacology, Pharmacotherapy +12

Relationship between Solubility of Chitosan in Alcoholic Solution and Its Gelation.

Motohiko Sano, Osamu Hosoya, Shose TAOKA et al. · Chemical and Pharmaceutical Bulletin · 1999 · 38 citations · Full text

Pharmacy, Pharmaceutics, Drug Delivery +16

Oogenesis and ovarian development cycle of the spiny lobster <i>Panulirus japonicus</i> (Decapoda:Palinuridae)

Megumi Minagawa, Motohiko Sano · Marine and Freshwater Research · 1998 · 36 citations

Life Sciences, Animal Sciences, Biology +8

Discrepancy between the NCI-CTCAE and DEB-NTC scales in the evaluation of oxaliplatin-related neurotoxicity in patients with metastatic colorectal cancer

Naohiko INOUE, Hideyuki Ishida, Motohiko Sano et al. · International Journal of Clinical Oncology · 2011 · 29 citations

Pharmacy, Oncology, Pharmacology +15